KBP-7018

Overview

KBP-7018 is an orally active, tyrosine kinase-selective multi-kinase inhibitor with an IC 50 value of 10 nM against c-KIT , 7.6 nM against RET , and 25 nM against human PDGFR . KBP-7018 improves survival rates in a mouse model of pulmonary fibrosis. KBP-7018 can be used in research related to idiopathic pulmonary fibrosis.

Application

Products | Products > Disease Areas > Lung Fibrosis | Products > Disease Areas > Respiratory Disease | Products > Disease Areas > Pulmonary Disease | Products > Signaling Pathways > Protein Tyrosine Kinase/RTK | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Inflammation/Immunology | Products > Signaling Pathways > c-Kit | Products > Signaling Pathways > RET | Products > Signaling Pathways > PDGFR | Products > Signaling Pathways > Cytochrome P450

Product Information

• Catalog No.: HY-117873
• CAS No.: 1613437-66-3
• Molecular Formula: C31H30N4O5
• Molecular Weight: 538.59
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source